Znanstveni rad - Izvorni znanstveni rad
Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
Antibiotics, 10 (2021), 7; 780. https://doi.org/10.3390/antibiotics10070780

Šamadan, Lara; Jeličić, Mia; Vince, Adriana; Papić, Neven

Citirajte ovaj rad

Šamadan, L., Jeličić, M., Vince, A. i Papić, N. (2021). Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection. Antibiotics, 10. (7). doi: 10.3390/antibiotics10070780

Šamadan, Lara, et al. "Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection." Antibiotics, vol. 10, br. 7, 2021. https://doi.org/10.3390/antibiotics10070780

Šamadan, Lara, Mia Jeličić, Adriana Vince i Neven Papić. "Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection." Antibiotics 10, br. 7 (2021). https://doi.org/10.3390/antibiotics10070780

Šamadan, L., et al. (2021) 'Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection', Antibiotics, 10(7). doi: 10.3390/antibiotics10070780

Šamadan L, Jeličić M, Vince A, Papić N. Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection. Antibiotics [Internet]. 27.06.2021. [pristupljeno 19.05.2024.];10(7). doi: 10.3390/antibiotics10070780

L. Šamadan, M. Jeličić, A. Vince i N. Papić, "Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection", Antibiotics, vol. 10, br. 7, Lipanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:748382. [Citirano: 19.05.2024.]